SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 28th, 2020 • BioLineRx Ltd. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 26, 2020, between BioLineRx Ltd., a company organized under the laws of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENT WARRANT TO PURCHASE AMERICAN DEPOSITARY SHARES BIOLINERX LTD.BioLineRx Ltd. • May 28th, 2020 • Pharmaceutical preparations
THIS PLACEMENT AGENT WARRANT TO PURCHASE AMERICAN DEPOSITARY SHARES (this “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after May 28, 2020 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on November 28, 2022 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BIOLINERX LTD., a company organized under the laws of the State of Israel (the “Company”), up to [•] Ordinary Shares, par value NIS 0.10 per share, of the Company (the “Warrant Shares”) represented by [•] American Depositary Shares (each, an “ADS” and, collectively, the “ADSs” and the ADSs issuable upon exercise of this Warrant, the “Warrant ADSs”), as subject to adjustment hereunder. The purchase price of one Warrant ADS shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant
